Cargando…
Efficacy of Semaglutide in a Subcutaneous and an Oral Formulation
Despite the benefits of early and effective glycemic control in the management of type 2 diabetes (T2D), achieving glycated hemoglobin (HbA(1c)) targets is challenging in some patients. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) provide effective reductions in HbA(1c) and body weight. Sema...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269445/ https://www.ncbi.nlm.nih.gov/pubmed/34248838 http://dx.doi.org/10.3389/fendo.2021.645617 |